Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma

NCT03835871 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: 400 µg per day Beclomethasone
DRUG: 200 µg per day Beclomethasone
DRUG: 100 µg per day Beclomethasone

Sponsor

Adamis Pharmaceuticals Corporation